MARKET

CGC

CGC

Canopy Growth
NASDAQ

Real-time Quotes | Nasdaq Last Sale

33.24
-2.01
-5.70%
Pre Market: 32.95 -0.29 -0.87% 07:30 03/04 EST
OPEN
35.28
PREV CLOSE
35.25
HIGH
35.50
LOW
32.97
VOLUME
8.10K
TURNOVER
--
52 WEEK HIGH
56.50
52 WEEK LOW
9.00
MARKET CAP
12.53B
P/E (TTM)
-6.4921
1D
5D
1M
3M
1Y
5Y
DJ Pot or Alcohol, Barron's Has Never Favored Prohibition -- Barrons.com
Dow Jones · 2h ago
Comviva introduces Data Science-as-a-Service (DSaaS) and AI workbench (MobiLytix AIX) solutions to enhance returns from Customer Value Management Programs
NEW DELHI, March 4, 2021 /CNW/ -- Comviva, the global leader in providing mobility solutions today announced the launch of its new Data-Science-as-a-Service (DSaaS) and AI workbench (MobiLytix AIX) solutions that accelerate the use of AI by Communications ...
CNW Group · 4h ago
Pot producer Green Thumb partners with Gwyneth Paltrow-backed beverages brand
Pot producer Green Thumb partners with Gwyneth Paltrow-backed beverages brand
reuters.com · 15h ago
Cramer Advises Viewers On Palo Alto, Pfizer, Zillow And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said his favorite stock in the cybersecurity sector is Palo Alto Networks Inc (NYSE: PANW).
Benzinga · 19h ago
Canadians Spent Big Money on Cannabis Products in 2020, and New 2.0 SKUs Could Boost Sales Higher
, /PRNewswire/ -- After overcoming some significant roadblocks since legalization in 2018, the Canadian regulated cannabis industry had a huge year in 2020. Canadians more than doubled their purchases from 2019, buying last year—a 120% increase year over...
PR Newswire - PRF · 22h ago
The CBD Vape Oil Market is Already Seeing Soaring Demand
The CBD vape market is expected to gain momentum. In fact, according to Data Bridge Market Research, the market could be worth up to $28.05 billion by 2027 at a CAGR of 22.25%. “Increasing CBD oil usage in several medical applications ...
Baystreet.ca · 23h ago
Cramer's lightning round: I think Zillow is a buy
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 1d ago
Top Marijuana Stock Times New CBD Drink Launch With Astrological Event
Investor's Business Daily · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CGC. Analyze the recent business situations of Canopy Growth through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Underperform

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CGC stock price target is 36.10 with a high estimate of 58.78 and a low estimate of 22.79.
EPS
Institutional Holdings
Institutions: 541
Institutional Holdings: 46.75M
% Owned: 12.41%
Shares Outstanding: 376.84M
TypeInstitutionsShares
Increased
120
6.74M
New
152
3.88M
Decreased
69
1.89M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.99%
Pharmaceuticals & Medical Research
-1.89%
Key Executives
Chairman/Independent Director
Judy Schmeling
President
Rade Kovacevic
Chief Executive Officer/Director
David Klein
Chief Financial Officer/Executive Vice President
Mike Lee
Senior Vice President
Thomas Shipley
Vice President/IR Contact Officer
Judy Hong
Chief Accounting Officer/Vice President
Thomas Stewart
Other
Phillip Shaer
Director
Jimes Sabia
Independent Director
Robert Hanson
Independent Director
David Lazzarato
Independent Director
William Newlands
Director
Terry Yanofsky
Independent Director
Theresa Yanofsky
No Data
About CGC
Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.

Webull offers kinds of Canopy Growth Corp stock information, including NASDAQ:CGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CGC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CGC stock methods without spending real money on the virtual paper trading platform.